Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Chan Lin

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 10, 2013
Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantationSu-Peng Yeh, Woei-Chung Lo, Ching-Yun Hsieh, et al.
The Oncologist|April 17, 2015
[18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal CarcinomaTe-Chun Hsieh, Ching Yun Hsieh, Tse Yen Yang, et al.
Cancers|March 28, 2024
Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid LeukemiaTzu-Ting Chen, Ching-Chan Lin, Wen-Jyi Lo, et al.
Scientific Reports|October 1, 2016
Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial CarcinomaShih-Yi Lin, Chao-Hsiang Chang, His-Chin Wu, et al.
International Journal of Hematology|February 28, 2022
Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignanciesTzu-Ting Chen, Ching-Chan Lin, Wen-Jyi Lo, et al.
American Journal of Cancer Research|May 10, 2024
ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progressionJing-Pei Liu, Kuan-Yin Shen, Wei-Chung Cheng, et al.
Molecular Oncology|April 4, 2023
Inhibition of CDCP1 by 8-isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatmentSze-Ching Wong, Chun-Chieh Yeh, Xun-Yu Zhang, et al.
Anticancer Research|April 3, 2020
Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiationChen-Yuan Lin, Hsin-Yuan Fang, Ming-Yu Lein, et al.
Oncotarget|May 25, 2017
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasisKuo-Liang Chiu, Yu-Sen Lin, Ting-Ting Kuo, et al.
Investigational New Drugs|June 4, 2025
A phase I study of liposomal Irinotecan (ONIVYDE®) in combination with TAS-102 (LONSURF®) in refractory solid tumorsNai-Jung Chiang, Li-Yuan Bai, I-Wei Ho, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 10, 2013
Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving allogeneic hematopoietic stem cell transplantationSu-Peng Yeh, Woei-Chung Lo, Ching-Yun Hsieh, et al.
The Oncologist|April 17, 2015
[18F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value as a Predictor of Adjuvant Chemotherapy Benefits in Patients With Nasopharyngeal CarcinomaTe-Chun Hsieh, Ching Yun Hsieh, Tse Yen Yang, et al.
Cancers|March 28, 2024
Venetoclax Plus Azacitidine as a Bridge Treatment to Allogeneic Stem Cell Transplantation in Unfit Patients with Acute Myeloid LeukemiaTzu-Ting Chen, Ching-Chan Lin, Wen-Jyi Lo, et al.
Scientific Reports|October 1, 2016
Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial CarcinomaShih-Yi Lin, Chao-Hsiang Chang, His-Chin Wu, et al.
International Journal of Hematology|February 28, 2022
Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignanciesTzu-Ting Chen, Ching-Chan Lin, Wen-Jyi Lo, et al.
American Journal of Cancer Research|May 10, 2024
ADAM9 drives the immunosuppressive microenvironment by cholesterol biosynthesis-mediated activation of IL6-STAT3 signaling for lung tumor progressionJing-Pei Liu, Kuan-Yin Shen, Wei-Chung Cheng, et al.
Molecular Oncology|April 4, 2023
Inhibition of CDCP1 by 8-isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatmentSze-Ching Wong, Chun-Chieh Yeh, Xun-Yu Zhang, et al.
Anticancer Research|April 3, 2020
Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiationChen-Yuan Lin, Hsin-Yuan Fang, Ming-Yu Lein, et al.
Oncotarget|May 25, 2017
ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasisKuo-Liang Chiu, Yu-Sen Lin, Ting-Ting Kuo, et al.
Investigational New Drugs|June 4, 2025
A phase I study of liposomal Irinotecan (ONIVYDE®) in combination with TAS-102 (LONSURF®) in refractory solid tumorsNai-Jung Chiang, Li-Yuan Bai, I-Wei Ho, et al.
Pageof 4